Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1952 1
1953 1
1954 4
1955 4
1957 3
1958 2
1961 1
1962 1
1965 1
1966 1
1972 1
1975 1
1978 1
1979 1
1983 1
1984 3
1985 1
1986 2
1988 2
1990 2
1991 1
1993 1
1994 1
1995 1
1996 2
1997 3
1999 2
2000 5
2001 19
2002 17
2003 11
2004 6
2005 5
2006 9
2007 8
2008 18
2009 14
2010 7
2011 8
2012 10
2013 8
2014 4
2015 6
2016 3
2017 7
2018 4
2019 7
2020 5
2021 4
2022 5
2023 6
2024 4
2025 4
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors.
Schmidt J, Chiffelle J, Perez MAS, Magnin M, Bobisse S, Arnaud M, Genolet R, Cesbron J, Barras D, Navarro Rodrigo B, Benedetti F, Michel A, Queiroz L, Baumgaertner P, Guillaume P, Hebeisen M, Michielin O, Nguyen-Ngoc T, Huber F, Irving M, Tissot-Renaud S, Stevenson BJ, Rusakiewicz S, Dangaj Laniti D, Bassani-Sternberg M, Rufer N, Gfeller D, Kandalaft LE, Speiser DE, Zoete V, Coukos G, Harari A. Schmidt J, et al. Among authors: guillaume p. Nat Commun. 2023 Jun 6;14(1):3188. doi: 10.1038/s41467-023-38946-z. Nat Commun. 2023. PMID: 37280206 Free PMC article.
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.
Saillard M, Cenerenti M, Reichenbach P, Guillaume P, Su Z, Hafezi M, Schmidt J, Cesbron J, Genolet R, Queiroz L, Racle J, Villard J, Renella R, Michielin O, Zoete V, Rivals JP, Irving M, Speiser DE, Harari A, Gfeller D, Adotevi O, Ceppi F, Coukos G, Romero P, Jandus C. Saillard M, et al. Among authors: guillaume p. Sci Adv. 2025 Jun 27;11(26):eadu5754. doi: 10.1126/sciadv.adu5754. Epub 2025 Jun 27. Sci Adv. 2025. PMID: 40577481 Free PMC article.
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.
Laheurte C, Boullerot L, Ndao B, Malfroy M, Queiroz L, Guillaume P, Loyon R, Seffar E, Gravelin E, Renaudin A, Jacquin M, Meurisse A, Vernerey D, Ghiringhelli F, Godet Y, Genolet R, Jandus C, Borg C, Adotévi O. Laheurte C, et al. Among authors: guillaume p. Cell Rep Med. 2025 Jul 15;6(7):102196. doi: 10.1016/j.xcrm.2025.102196. Epub 2025 Jun 20. Cell Rep Med. 2025. PMID: 40543509 Free PMC article. Clinical Trial.
Regulatory T cell therapy for xenotransplantation, what perspectives?
Porret R, Lana E, Mancarella A, Guillaume P, Pascual M, Meier RPH, Bromberg JS, Mohiuddin MM, Buhler LH, Tang Q, Muller YD. Porret R, et al. Among authors: guillaume p. Front Immunol. 2025 Sep 19;16:1685682. doi: 10.3389/fimmu.2025.1685682. eCollection 2025. Front Immunol. 2025. PMID: 41050672 Free PMC article. Review.
Dual CD8 and TCR editing in regulatory T cells mediates HLA-A2-restricted tissue-specific homing.
Porret R, Lebreton F, Pace E, Stefanidis E, Semilietof A, Guillaume P, Georgakis S, Alfageme-Abello O, Alcaraz-Serna A, Ermellino L, Cecchin R, Lana E, Hafezi M, Procopio F, Bellofatto K, Giordano Attianese GMP, Zoete V, Perreau M, Petrovas C, Irving M, Berishvili E, Tang Q, Muller YD. Porret R, et al. Among authors: guillaume p. Mol Ther. 2026 Jun 3;34(6):3388-3404. doi: 10.1016/j.ymthe.2026.02.028. Epub 2026 Feb 18. Mol Ther. 2026. PMID: 41709576 Free article.
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.
Ben Khelil M, Fredon M, Adib N, Bouard A, Perchaud M, Abdeljaoued S, Mantion CF, Asgarov K, Guillaume P, Spehner L, Seffar E, Labesse M, Vienot A, Mougey V, Gonçalves-Venturelli M, Bobisse S, Harari A, Jandus C, Garnache-Ottou F, Binda D, Adotévi O, Godet Y, Kroemer M, Borg C, Loyon R. Ben Khelil M, et al. Among authors: guillaume p. Cancer Immunol Res. 2026 Jan 8;14(1):139-154. doi: 10.1158/2326-6066.CIR-24-0207. Cancer Immunol Res. 2026. PMID: 41114529
Deciphering the landscape of phosphorylated HLA-II ligands.
Solleder M, Racle J, Guillaume P, Coukos G, Bassani-Sternberg M, Gfeller D. Solleder M, et al. Among authors: guillaume p. iScience. 2022 Apr 6;25(5):104215. doi: 10.1016/j.isci.2022.104215. eCollection 2022 May 20. iScience. 2022. PMID: 35494241 Free PMC article.
Dose to organ at risk and dose prescription in liver SBRT.
Michel R, Françoise I, Laure P, Anouchka M, Guillaume P, Sylvain K. Michel R, et al. Among authors: guillaume p. Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):96-102. doi: 10.1016/j.rpor.2017.03.001. Epub 2017 Apr 17. Rep Pract Oncol Radiother. 2017. PMID: 28490979 Free PMC article. Review.
Sensitive identification of neoantigens and cognate TCRs in human solid tumors.
Arnaud M, Chiffelle J, Genolet R, Navarro Rodrigo B, Perez MAS, Huber F, Magnin M, Nguyen-Ngoc T, Guillaume P, Baumgaertner P, Chong C, Stevenson BJ, Gfeller D, Irving M, Speiser DE, Schmidt J, Zoete V, Kandalaft LE, Bassani-Sternberg M, Bobisse S, Coukos G, Harari A. Arnaud M, et al. Among authors: guillaume p. Nat Biotechnol. 2022 May;40(5):656-660. doi: 10.1038/s41587-021-01072-6. Epub 2021 Nov 15. Nat Biotechnol. 2022. PMID: 34782741 Free PMC article.
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
Genolet R, Bobisse S, Chiffelle J, Arnaud M, Petremand R, Queiroz L, Michel A, Reichenbach P, Cesbron J, Auger A, Baumgaertner P, Guillaume P, Schmidt J, Irving M, Kandalaft LE, Speiser DE, Coukos G, Harari A. Genolet R, et al. Among authors: guillaume p. Cell Rep Methods. 2023 Apr 24;3(4):100459. doi: 10.1016/j.crmeth.2023.100459. eCollection 2023 Apr 24. Cell Rep Methods. 2023. PMID: 37159666 Free PMC article.
234 results